Results 11 to 20 of about 6,792 (211)

Hereditary hemorrhagic telangiectasia associated with inherited thrombophilia [PDF]

open access: yesVojnosanitetski Pregled, 2017
Introduction. Hereditary hemorrhagic telangiectasia and inherited thrombophilia are genetic disorders with quite opposite clinical manifestation. The main characteristic for hereditary hemorrhagic telangiectasia is recurrent bleeding, while the ...
Roganović Branka   +3 more
doaj   +2 more sources

Splenic Involvement in Hereditary Hemorrhagic Telangiectasia

open access: yesCase Reports in Medicine, 2016
A 33-year-old man who presented with prolonged epigastric pain was referred to our hospital. He had experienced recurrent epistaxis and had a family history of hereditary hemorrhagic telangiectasia.
Susumu Takamatsu   +5 more
doaj   +2 more sources

Genetic Diagnosis of Hereditary Hemorrhagic Telangiectasia: Four Novel Pathogenic Variations in Turkish Patients

open access: yesBalkan Medical Journal, 2020
Aims:Hereditary hemorrhagic telangiectasia is an autosomal dominant disorder characterized by telangiectasia, epistaxis, and vascular malformations. Pathogenic mutations were found in ENG, AVCRL1, SMAD4, and GDF genes.
Mehmet Baysal   +8 more
doaj   +2 more sources

The Lung in Hereditary Hemorrhagic Telangiectasia [PDF]

open access: yesRespiration, 2017
Hereditary hemorrhagic telangiectasia (HHT) is a dominantly inherited genetic vascular disorder with an estimated prevalence of 1 in 6,000, characterized by recurrent epistaxis, cutaneous telangiectasia, and arteriovenous malformations (AVMs) that affect many organs including the lungs, gastrointestinal tract, liver, and brain.
Sophie Dupuis-Girod   +2 more
openaire   +5 more sources

A Case of Hereditary Hemorrhagic Telangiectasia [PDF]

open access: yesAnnals of Dermatology, 2009
Hereditary hemorrhagic telangiectasia, also known as Osler-Weber-Rendu disease, is an autosomal dominant disorder of the fibrovascular tissue. It is characterized by the classic triad of mucocutaneous telangiectasias, recurrent hemorrhages, and familial occurrence.
Ha Eun, Lee   +5 more
openaire   +3 more sources

Hereditary hemorrhagic telangiectasia, embolization, and Young’s procedure: oral surgical management

open access: yesJournal of Oral Medicine and Oral Surgery, 2018
Hereditary hemorrhagic telangiectasia (HHT) case with history of embolization and Young’s procedure: surgical management. Introduction: Osler–Weber–Rendu disease hereditary hemorrhagic telangiectasia (HHT) is a genetic vascular dysplasia.
Malthiery Eve   +5 more
doaj   +2 more sources

Radiofrequency for Treatment of Refractory Epistaxis in Hereditary Hemorrhagic Telangiectasia

open access: yesActa Médica Portuguesa, 2018
Hereditary hemorrhagic telangiectasia is a rare multi-systemic autosomal dominant disorder characterized by dysplasia of the vascular connective tissue and recurrent bleeding tendency. Epistaxis is the most common and earliest symptom. It is usually mild
Mariana Donato   +3 more
doaj   +3 more sources

10th International Hereditary Hemorrhagic Telangiectasia Scientific Conference, 12-15 June, 2013 - Cork, Ireland

open access: yesHematology Reports, 2013
Book of Abstracts - 10th International Hereditary Hemorrhagic Telangiectasia Scientific Conference, 12-15 June, 2013 - Cork ...
Guest Editors: Carmelo Bernabeu, Luisa M. Botella, Adrian Brady, Marie Faughnan, Urban Geisthoff
doaj   +2 more sources

9th International Hereditary Hemorrhagic Telangiectasia Scientific Conference, 20-24 May 2011 Kemer, Antalya – Turkey

open access: yesHematology Reports, 2011
Book of Abstracts - 9th International Hereditary Hemorrhagic Telangiectasia Scientific Conference, 20-24 May 2011 Kemer, Antalya ...
Guest Editor: Kevin Whitehead, USA
doaj   +2 more sources

Safely Treating a Pulmonary Embolism in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Hereditary Hemorrhagic Telangiectasia (HHT) is a rare autosomal dominant bleeding disorder. The incidence of venous thromboembolisms among HHT patients is significantly greater than the general population. However, providing therapeutic anticoagulation in patients with an increased propensity for bleeding creates a clinical dilemma.
Carfagnini C, Kandula M.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy